Ionis Pharmaceuticals
IONS
IONS
316 hedge funds and large institutions have $5.72B invested in Ionis Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 89 increasing their positions, 115 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
17% less call options, than puts
Call options by funds: $60.9M | Put options by funds: $73.5M
23% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 115
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
316
Holding in Top 10
5
Calls
$60.9M
Puts
$73.5M
Top Buyers
| 1 | +$22.6M | |
| 2 | +$13.8M | |
| 3 | +$13.3M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$12.3M |
| 5 |
Goldman Sachs
New York
|
+$12.2M |
Top Sellers
| 1 | -$58.8M | |
| 2 | -$29.2M | |
| 3 | -$26.1M | |
| 4 |
ClearBridge Investments
New York
|
-$22.9M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$17.9M |